MedTrace Logo

SwissTAVI Registry

NCT01368250 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2024-05-23

No results posted yet for this study

Summary

The purpose of this prospective multi-center, observational national registry in Switzerland is to obtain clinical baseline, procedural and follow-up data of all patients treated with TAVI in Switzerland and to assess short, mid- and long-term clinical outcome data of the CE approved devices. All centers in Switzerland implanting the CE approved devices for TAVI will be invited to include patients in the registry. Each site will collect baseline and procedural data as well as clinical outcome data up to five years.

Conditions

  • Aortic Valve Disease Mixed

Interventions

PROCEDURE

Transcatheter Aortic Valve Implantation

Minimal Invasive Implantation of a biological prosthesis in Aortic Position

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Stefan Stortecky, MD · Bern University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2025-05-31
Completion
2025-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01368250 on ClinicalTrials.gov